IVF Devices And Consumables Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 3.28 Billion |
| Market Size (2029) | USD 7.19 Billion |
| CAGR (2024 - 2029) | 16.99 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
IVF Devices And Consumables Market Analysis
The Global IVF Devices And Consumables Market size is estimated at USD 3.28 billion in 2024, and is expected to reach USD 7.19 billion by 2029, growing at a CAGR of 16.99% during the forecast period (2024-2029).
The key factor driving the market for in vitro fertilization (IVF) devices and consumables is the increasing prevalence of infertility and advancements in reproductive technologies. Further, the rising awareness about infertility treatments, coupled with innovations in IVF techniques and improved success rates, is driving demand for advanced IVF devices and consumables.
Infertility cases are on the rise globally, which will propel the growth of the market during the forecast period. For instance, as per the Center for Disease Control and Prevention updates in April 2024, the general fertility rate in the United States decreased by 3% from 2022. Consequently, rising demand for in vitro fertilization, driven by declining fertility rates, drives market growth. Additionally, government initiatives aimed at combating infertility further bolster this growth. For instance, in August 2024, Japan's Tokyo Metropolitan Government expanded its subsidy program for elective egg freezing to address its declining fertility rate. However, stringent regulations present challenges by mandating written consent from a legal spouse, thereby restricting access for single women and LGBTQ+ professionals. While the program saw a surge in interest with over 7,000 applicants, studies indicate a stark reality: only 15% of women utilize frozen eggs. Hence, these government initiatives to reduce the economic burden of a couple undergoing in vitro fertilization treatment are expected to increase the market share in the upcoming years.
Additionally, the rising research studies for innovation in IVF devices and consumables and increasing product launches contribute to market growth. For instance, in a research study published in the journal of the Royal Society of Chemistry in March 2022, researchers from Florida Atlantic University's College of Engineering and Computer Science developed a microfluidic chip for sperm sorting that is fast, inexpensive, easy to operate and isolates healthy sperm directly from semen. The sperm cells isolated in this microfluidic chip exhibited significantly higher motility, a vital parameter for fertilization. Such advancements in research studies are expected to create a demand for these products to treat infertility, propelling the market growth.
Therefore, the market is anticipated to grow during the forecast period owing to factors such as the high prevalence of infertility and rising research studies leading to technological advancements in IVF devices and consumables. However, the low success rate of IVF procedures and the high cost of devices are likely to impede market growth.
IVF Devices And Consumables Market Trends
Fertility Clinics are Expected to Hold a Significant Market Share During the Forecast Period
Fertility clinics provide specialized care and advanced infrastructure necessary for complex IVF procedures. The presence of experienced specialists and the ability to offer tailored treatment plans contribute to the growing market share. Additionally, the increasing acceptance of infertility as a medical issue reduces stigma, encouraging more individuals to seek help. Fertility clinics are poised to capture a substantial market share, driven by the rising adoption of assisted reproductive technology (ART) and escalating global infertility rates.
The growing demand for infertility treatment and increasing visits to fertility clinics for treatment are expected to contribute to the segment growth. For instance, in April 2024, the Society for Assisted Reproductive Technology (SART), representing America's fertility clinics, unveiled its latest national and clinic-specific data on assisted reproductive technologies (ART). The number of babies born through IVF rose from 89,208 in 2021 to 91,771 in 2022. This increase signifies that 2.5% of all United States births stem from successful ART cycles. Despite challenging legislation and potential political interference, the rising number of cycles underscores a robust demand for fertility services. At the 368 SART member clinics, the total IVF cycles surged by over 6% from 2021, climbing from 368,502 to 389,993 in 2022. As a result, increasing awareness of IVF treatments is projected to drive the segment growth in the coming years.
Similarly, the establishment of fertility clinics is another factor in the growth of the segment. For instance, in June 2024, Kindbody, a prominent national network of fertility clinics and a global provider of family-building benefits for employers, inaugurated a cutting-edge fertility clinic in California, United States. Similarly, in June 2024, Nahyan bin Mubarak officially opened the ART Fertility Clinic in Al Ain City. This state-of-the-art facility elevates the standards of IVF services and stands as a significant boon for the residents of Al Ain. Such launches will likely increase market growth in the future.
Additionally, in September 2022, Indira IVF, a leading fertility clinic chain in India, announced its intention to acquire multi-center IVF clinics in Tamil Nadu and Kerala. This move aims to bolster Indira IVF's foothold in South India. As these fertility clinics expand across various districts and states, the demand for IVF devices and consumables during treatment procedures is anticipated to rise, fueling growth in this segment.
Given the rising awareness of fertility treatments and the expanding number of fertility clinics, the segment is poised for substantial growth during the forecast period.
North America is Expected to Hold a Significant Market Share During the Forecast Period
North America is expected to hold a significant market share owing to the rising prevalence of infertility, the high availability of infertility clinics, and technological advancements in IVF devices and consumables by market players.
The increase in the treatment of IVF in the United States is expected to increase demand for IVF devices and consumables. It is expected to propel the growth of the market during the forecast period. For instance, in April 2024, the Society for Assisted Reproductive Technology (SART) reported that the United States conducted 389,993 IVF cycles in 2022, marking a rise of over 6% from the previous year. Among these, 29,803 were egg-freezing cycles, a notable increase from 24,560 in 2021. Thus, increasing adoption of IVF in the region is expected to drive demand for IVD devices and consumables, contributing to market growth.
Low birth rates also contribute to the growth of the market. According to an article from Statistics Canada in March 2022, Canada has low fertility rates. If the fertility rate continues to decline in the coming years, Canada could be grouped with countries with the lowest fertility rates, defined as 1.3 or fewer children per woman. Therefore, the high infertility prevalence in the region is expected to boost the demand for IVF procedures, which is expected to propel the market growth during the forecast period.
The strategic initiatives adopted by industry players, such as product launches, partnerships, and expansions, are another factor in the growth of the market. For instance, in March 2024, TMRW Life Sciences (TMRW) unveiled CryoLink, a cutting-edge workstation designed to oversee frozen specimen inventories in fertility clinics digitally. With the launch of CryoLink, clinics can easily incorporate TMRW's Digital Specimen Management system, regardless of whether they use TMRW's automated storage solutions. Hence, such partnerships will expand the IVF treatment options in the region, which is expected to propel the demand for IVF devices and consumables during the forecast period.
Therefore, due to the above factors, such as the high availability of fertility clinics and growing treatment, low fertility rate, and rising strategic initiatives by market players, the market is likely to grow in the future.
IVF Devices And Consumables Industry Overview
Most of the players are based in developing countries due to more technological advancements. However, due to the ease of connectivity in modern times, these players have also penetrated developing countries and are trying to establish a market. The market is semi-consolidated and consists of several major players. Some companies dominating the market are Cook Group, CooperSurgical Fertility Company, FUJIFILM Holdings Corporation, and Thermo Fisher Scientific.
IVF Devices And Consumables Market Leaders
-
Cook Group
-
CooperSurgical Fertility Company
-
Merck KGaA
-
Thermo Fisher Scientific
-
FUJIFILM Holdings Corporation
*Disclaimer: Major Players sorted in no particular order
IVF Devices And Consumables Market News
- May 2024: Cook Medical entered a letter of intent with Astorg, a prominent private equity firm renowned for its successful global healthcare investments, to acquire Cook's Reproductive Health division, "Cook ART". The transaction encompasses products related to in vitro fertilization (IVF) and assisted reproductive technology (ART).
- March 2024: Alife Health forged a pioneering alliance with Boston IVF, a prominent fertility clinic boasting over 25 US locations, to test the nation's inaugural AI tool for optimizing IVF medications.
IVF Devices & Consumables Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Global Infertility Rates and Delayed Pregnancies Among Women
- 4.2.2 Rising Research and Development for Technological Advancement in IVF Devices
-
4.3 Market Restraints
- 4.3.1 Low Success Rate of IVF Procedures and High Cost of Devices
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Type
- 5.1.1 Instrument
- 5.1.1.1 Sperm Separation System
- 5.1.1.2 Incubator
- 5.1.1.3 Cryosystem
- 5.1.1.4 Other Instruments
- 5.1.2 Reagents and Media
- 5.1.2.1 Cryopreservation Media
- 5.1.2.2 Semen Processing Media
- 5.1.2.3 Other Reagents and Mdedia
- 5.1.3 Accessories and Disposable
-
5.2 By Technology
- 5.2.1 Fresh Embryo IVF
- 5.2.2 Frozen Embryo IVF
- 5.2.3 Donor Egg IVF
-
5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Fertility Clinics
- 5.3.3 Other End Users
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Cook Group
- 6.1.2 CooperSurgical
- 6.1.3 Esco Medical
- 6.1.4 FUJIFILM Holdings Corporation
- 6.1.5 Genea Biomedx
- 6.1.6 Hamilton Thorne Inc.
- 6.1.7 Memmert GmbH + Co. KG
- 6.1.8 Merck KGaA
- 6.1.9 Nidacon International AB
- 6.1.10 Thermo Fisher Scientific
- 6.1.11 Vitrolife
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityIVF Devices And Consumables Industry Segmentation
As per the scope of the report, in vitro fertilization is a medical procedure whereby an egg is fertilized by sperm in a test tube or elsewhere outside the body. The scope includes medical devices, media, and consumables utilized in the process.
The IVF devices and consumables market is segmented by type, technology, end user, and geography. By type, the market is segmented as instruments, reagents and media, and accessories and disposables. By technology, the market is segmented as fresh embryo IVF, frozen embryo IVF, and donor egg IVF. By end user, the market is segmented as hospitals, fertility clinics, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers market size and forecasts for the IVF devices and consumables market in value (USD) for all the above segments.
| By Type | Instrument | Sperm Separation System |
| Incubator | ||
| Cryosystem | ||
| Other Instruments | ||
| By Type | Reagents and Media | Cryopreservation Media |
| Semen Processing Media | ||
| Other Reagents and Mdedia | ||
| By Type | Accessories and Disposable | |
| By Technology | Fresh Embryo IVF | |
| Frozen Embryo IVF | ||
| Donor Egg IVF | ||
| By End User | Hospitals | |
| Fertility Clinics | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
IVF Devices & Consumables Market Research FAQs
How big is the Global IVF Devices And Consumables Market?
The Global IVF Devices And Consumables Market size is expected to reach USD 3.28 billion in 2024 and grow at a CAGR of 16.99% to reach USD 7.19 billion by 2029.
What is the current Global IVF Devices And Consumables Market size?
In 2024, the Global IVF Devices And Consumables Market size is expected to reach USD 3.28 billion.
Who are the key players in Global IVF Devices And Consumables Market?
Cook Group, CooperSurgical Fertility Company, Merck KGaA, Thermo Fisher Scientific and FUJIFILM Holdings Corporation are the major companies operating in the Global IVF Devices And Consumables Market.
Which is the fastest growing region in Global IVF Devices And Consumables Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global IVF Devices And Consumables Market?
In 2024, the North America accounts for the largest market share in Global IVF Devices And Consumables Market.
What years does this Global IVF Devices And Consumables Market cover, and what was the market size in 2023?
In 2023, the Global IVF Devices And Consumables Market size was estimated at USD 2.72 billion. The report covers the Global IVF Devices And Consumables Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global IVF Devices And Consumables Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
IVF Devices & Consumables Industry Report
Statistics for the 2023 IVF Devices & Consumables market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. IVF Devices & Consumables analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
